跳转至内容
Merck

638617

Sigma-Aldrich

2-(三正丁基锡基)噁唑

别名:

2-(Tributylstannanyl)-1,3-oxazole, 2-(Tributylstannanyl)oxazole, 2-(Tributylstannyl)-1,3-oxazole, 2-(Tributylstannyl)oxazole, Tributyl(oxazol-2-yl)stannane

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C15H29NOSn
分子量:
358.11
MDL號碼:
分類程式碼代碼:
12352103
PubChem物質ID:
NACRES:
NA.22

折射率

n20/D 1.4930 (lit.)

bp

108-110 °C/0.2 mmHg (lit.)

密度

1.170 g/mL at 25 °C
1.71 g/mL at 25 °C (lit.)

SMILES 字串

CCCC[Sn](CCCC)(CCCC)c1ncco1

InChI

1S/3C4H9.C3H2NO.Sn/c3*1-3-4-2;1-2-5-3-4-1;/h3*1,3-4H2,2H3;1-2H;

InChI 密鑰

YOWGRWHKDCHINP-UHFFFAOYSA-N

一般說明

2-(Tri-n-butylstannyl)oxazole is a synthetic building block used in Stille coupling reaction.

應用

2-(Tri-n-butylstannyl)oxazole can be used as a reactant to prepare:
  • Heteroaromatic compounds via Stille-Migita cross-coupling reaction with (hetero)aryl halides using a palladium catalyst.
  • Ethyl 2-[3-(1,3-oxazol-2-yl)-1H-indazol-1-yl]acetate by reacting with 3-iodoindazole in the presence of Pd(PPh3)4 as a catalyst.

訊號詞

Danger

危險分類

Acute Tox. 3 Oral - Acute Tox. 4 Dermal - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Repr. 1B - Skin Irrit. 2 - STOT RE 1

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Efficient synthesis of new 3-heteroaryl-1-functionalized 1H-indazoles
Fraile A, et al.
Tetrahedron, 67(1), 100-105 (2011)
Oliver Krebs et al.
Organic letters, 7(6), 1063-1066 (2005-03-12)
[structure: see text] A strategy for the synthesis of ajudazol A, an unusual, pharmacologically active metabolite from myxobacteria, based on the Stille cross-coupling of a 2-stannyl-oxazole with a vinyl iodide unit is described; the vinyl halide unit containing a (Z,Z)-diene
Jacob A Kaizerman et al.
Bioorganic & medicinal chemistry letters, 20(15), 4607-4610 (2010-07-03)
Pyridopyridazine antagonists of the hedgehog signaling pathway are described. Designed to optimize our previously described phthalazine smoothened antagonists, a representative compound eliminates a PXR liability while retaining potency and in vitro metabolic stability. Moreover, the compound has improved efficacy in

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门